The three major indices of A-shares in Shanghai and Shenzhen opened with narrow differentiation, and some innovative drug concept stocks continued to rise
According to CCTV reports, the first meeting of the China-U.S. economic and trade consultation mechanism continued today (10th).
The People's Bank of China conducted a 198.6 billion yuan (the same below) seven-day reverse repurchase operation in the open market today, with the operation rate remaining at 1.4%. Today, 454.5 billion yuan of reverse repos are maturing, resulting in a net withdrawal of 255.9 billion yuan for the day. The central parity rate of the yuan against the U.S. dollar is reported at 7.1840, up 15 points.
The three major A-share indices opened mixed. The Shanghai Composite Index opened at 3,402 points, up 2 points or 0.07%. The Shenzhen Component Index opened at 10,248 points, down 1 point or 0.02%. The ChiNext Index opened at 2,057 points, down 3 points or 0.2%.
Domestic bank stocks, China Construction Bank (601939.SH) and Industrial and Commercial Bank of China (601398.SH), both opened flat. In addition, BYD (002594.SZ) opened up 0.4%. Contemporary Amperex Technology Co., Limited (300750.SZ) opened down 0.2%.
Some innovative drug concept stocks rose, with Hicin Pharmaceutical (300584.SZ) and Qianhong Bio-pharma (002550.SZ) opening up approximately 4.1% and 4.2%, respectively